Erleada 240 mg, Filmtabletten - 2 x 14 Swissmedic Key 67072002 Registration Holder Janssen-Cilag AG Name Erleada 240 mg, Filmtabletten Date of registration 19.09.2019 Introduction of Sequence 06.10.2023 ATC-Classification Apalutamide (L02BB05) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.20. Show package size 2 x 14 Index Therapeuticus (Swissmedic) 07.16.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 3006.28 Limitation Yes Limitation text
Deductible 10 % Consumer price 3285.95 Feedback FB Daily cost GTIN 7680670720021 Medication Code Synthetika Pharmacode Disponibility
Composition apalutamidum 240 mg, hypromellosi acetas succinas, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium 6.11 mg, cellulosum microcristallinum silicificatum, magnesii stearas, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, E 171, glyceroli monocaprylocapras, poly(alcohol vinylicus), E 172 (nigrum), pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets BAG: Active Agent Dose 240 mg
Inactive agents additional_information Überzug color. color. Silica Colloidalis Anhydrica Talcum
Source Data was imported : 04.04.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
